AMGN
$255.26
One Year Performance +9.28%
| Sector | Healthcare | Beta | 0.58 | ETF | No | EPS | 10.12 |
| Industry | Drug Manufacturers—General | Last Div | 7.4 | 52W Range | 198.64-258.45 | Mkt Cap | 136,359,886,848 |
| IPO Since | 1987-05-01 | Exchange | NASDAQ | PE | 25.22 | Shares | 534,199,980 |
Who Has AMGN
|
|
|
|
|
|
|
|
|
Profitability
Profitability Indicators Chart
Profit Margin Chart
| TTM | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability Indicators | ||||||||||||
| Revenue Per Share | 48.02 | 44.33 | 43.39 | 38.61 | 35.93 | 31.26 | 30.74 | 28.58 | 26.43 | 24.8 | 22.28 | 17.22 |
| Earning Per Share | 10.44 | 10.06 | 12.4 | 12.96 | 12.7 | 2.71 | 10.32 | 9.15 | 6.8 | 6.75 | 5.61 | 4.07 |
| Operating Cash Flow Per Share | 17.01 | 15.8 | 17.91 | 15.12 | 17.09 | 15.29 | 13.84 | 11.97 | 11.27 | 8.35 | 7.59 | 5.66 |
| Free Cash Flow Per Share | 15.36 | 14.3 | 16.88 | 14.1 | 15.97 | 14.38 | 12.72 | 11.12 | 9.95 | 7.43 | 6.7 | 5.03 |
| Book Value Per Share | 1.67 | 11.43 | 16.06 | 15.99 | 18.91 | 34.53 | 39.94 | 37.05 | 33.96 | 29.34 | 24.59 | 21.03 |
| Gross Profit Margin % | 75.21 | 75.16 | 75.77 | 81.35 | 82.73 | 82.19 | 81.9 | 80.49 | 77.96 | 82.08 | 83.1 | 84.42 |
| Operating Profit Margin % | 30.44 | 29.4 | 35.95 | 41.41 | 43.22 | 43.65 | 42.6 | 39.1 | 30.86 | 31.41 | 32.3 | 27.67 |
| Tax Rate % | 12.21 | 12.06 | 10.68 | 14.18 | 12.06 | 79.38 | 15.73 | 13.02 | 7.65 | 3.49 | 13.26 | 11.25 |
| Net Profit Margin % | 21.75 | 22.68 | 28.57 | 33.57 | 35.35 | 8.66 | 33.59 | 32.03 | 25.71 | 27.21 | 25.17 | 23.64 |
| Profitability Growth (YoY) | ||||||||||||
| Revenue Growth % | - | 2.18 | 8.83 | -1.62 | 3.93 | -0.62 | 6.14 | 7.97 | 7.43 | 8.17 | 10.8 | 3.51 |
| EPS Growth % | - | -18.87 | -7.37 | -6.58 | 324.15 | -74.37 | 11.28 | 34.53 | 1.52 | 16.94 | 17.97 | -20.4 |
| Operating Cash Flow Growth % | - | -11.77 | 14.72 | -19 | 1.06 | 7.95 | 14.07 | 6.1 | 35.99 | 6.95 | 14.91 | -11.54 |
| Free Cash Flow Growth % | - | -15.25 | 15.9 | -19.19 | 0.43 | 10.47 | 12.92 | 11.6 | 34.91 | 7.8 | 14.08 | -12.58 |
| BVPS Growth % | - | -28.79 | 0.42 | -15.45 | -45.23 | -13.55 | 7.8 | 9.09 | 15.74 | 19.32 | 16.96 | -15.7 |
| Compound Annual Growth Rate Chart (CAGR) | 10Y CAGR | 7Y CAGR | 5Y CAGR | 3Y CAGR | ||||||||
| Revenue Per Share Growth % (CAGR) | - | 7.12 | 6.47 | 7.24 | 4.71 | |||||||
| Earning Per Share Growth % (CAGR) | - | 6.01 | 1.36 | 29.99 | -8.1 | |||||||
| Operating Cash Flow Per Share Growth % (CAGR) | - | 7.61 | 4.05 | 0.66 | 1.48 | |||||||
| Free Cash Flow Per Share Growth % (CAGR) | - | 7.88 | 3.66 | -0.11 | 0.47 | |||||||
| Book Value Per Share Growth % (CAGR) | - | -7.37 | -15.46 | -19.84 | -10.59 |
AMGN News Today
Amgen: Safe Harbor In Turbulent Times
Amgen can be a cornerstone in your portfolio due to its fortress financial strength, secular support, and strong profitability. At its present price levels, a dividend discount reveals a very asymmetric return profile with an upside near 40% but little downside.
Seeking Alpha 2022-05-21 06:51:00
How Are Biotech ETFs Reacting to These Q1 Earnings Releases?
Let's take a look at some big biotechnological earnings releases to see if these will impact ETFs exposed to the space.
Zacks Investment Research 2022-05-10 15:48:07
7 Defensive Dividend Healthcare Stocks to Buy Now
As market conditions remain rocky, adding high-quality healthcare stocks to your portfolio may be a great way to play defense. The post 7 Defensive Dividend Healthcare Stocks to Buy Now appeared first on InvestorPlace.
InvestorPlace 2022-05-06 07:33:52
Should Investors Be Worried About Amgen's Q1 Results?
Much of the company's growth isn't coming from its top-selling drugs.
The Motley Fool 2022-05-05 08:20:00
Amgen: Another Chance To Average Down
Amgen's recent results were encouraging, with strong underlying volume growth in key franchises. It has a number of growth prospects in its pipeline, including mid- to late-stage drugs in inflammation, oncology, and general medicine.
Seeking Alpha 2022-05-05 07:00:05
